Abstract
AIMS: To assess the accuracy and precision of INR measurement by trained practice and district nursing staff using the Thrombolytic Assessment System (TAS) analyser. METHODS: Seventeen nurses from four practices were trained to measure INR using the TAS analyser on citrated capillary blood samples. Quality control (QC) consisted of: daily internal QC using normal and abnormal commercial plasmas; monthly local external QC scheme using fresh citrated venous blood; and registration of all analysers in the NEQAS (national external quality assessment scheme) main users scheme. RESULTS: Analysis of internal QC results demonstrated satisfactory interanalyser and intra-analyser precision with no evidence of analytical drift in any of the four practice analysers over an eight month period. Local and national external QC results confirmed the interanalyser precision but INR was underestimated by the TAS analysers compared with the CA 1000 using either Diagen rabbit brain thromboplastin or Innovin, and with other NEQAS users. CONCLUSIONS: The TAS analyser has many features to commend it for use by nonpathology staff to determine INR. Local internal and external QC and entry into the NEQAS main users group are possible because the TAS analyses citrated plasma or blood. The TAS analyser underestimates INR when the geometric mean normal prothrombin time (GMNPT) is determined by conventional methods. A local correction factor can be introduced by adjusting the normal PT to give INR results comparable with the local laboratory. This is particularly desirable when INRs are measured using both near-patient and laboratory analytical systems on different occasions.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gage B. F., Cardinalli A. B., Albers G. W., Owens D. K. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA. 1995 Dec 20;274(23):1839–1845. [PubMed] [Google Scholar]
- Jennings I., Luddington R. J., Baglin T. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. J Clin Pathol. 1991 Nov;44(11):950–953. doi: 10.1136/jcp.44.11.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kitchen S., Walker I. D., Woods T. A., Preston F. E. Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Steering Committee of the UK National External Quality Assessment Scheme in Blood Coagulation. Thromb Haemost. 1994 Sep;72(3):426–429. [PubMed] [Google Scholar]
- Lip G. Y., Lowe G. D. ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation. BMJ. 1996 Jan 6;312(7022):45–49. doi: 10.1136/bmj.312.7022.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pi D. W., Raboud J. M., Filby C., Carter C. J. Effect of thromboplastin and coagulometer interaction on the precision of the International Normalised Ratio. J Clin Pathol. 1995 Jan;48(1):13–17. doi: 10.1136/jcp.48.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poller L., Triplett D. A., Hirsh J., Carroll J., Clarke K. The value of plasma calibrants in correcting coagulometer effects on international normalized ratios. An international multicenter study. Am J Clin Pathol. 1995 Mar;103(3):358–365. doi: 10.1093/ajcp/103.3.358. [DOI] [PubMed] [Google Scholar]